BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35874784)

  • 1. Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression.
    Wei Y; Zhang J; Fan X; Zheng Z; Jiang X; Chen D; Lu Y; Li Y; Wang M; Hu M; Du Q; Yang L; Li H; Xiao Y; Li Y; Jin J; Wang D; Yuan X; Li Q
    Front Immunol; 2022; 13():935552. PubMed ID: 35874784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response.
    Zhang B; Wang CM; Wu HX; Wang F; Chai YY; Hu Y; Wang BJ; Yu Z; Xia RH; Xu RH; Cao XT
    Cancer Commun (Lond); 2023 Oct; 43(10):1097-1116. PubMed ID: 37539769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Cell Landscape in Gastric Cancer.
    Yang Y; He W; Wang ZR; Wang YJ; Li LL; Lu JZ; Tao Y; Zhang J; Fu SJ; Wang ZP; Liu SH
    Biomed Res Int; 2021; 2021():1930706. PubMed ID: 33575321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 7. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
    Nakano H; Saito M; Nakajima S; Saito K; Nakayama Y; Kase K; Yamada L; Kanke Y; Hanayama H; Onozawa H; Okayama H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Goto A; Kono K
    Sci Rep; 2021 Jan; 11(1):1982. PubMed ID: 33479394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor antigen-specific CD8
    Lu X; Yang L; Yao D; Wu X; Li J; Liu X; Deng L; Huang C; Wang Y; Li D; Liu J
    Cell Immunol; 2017 Mar; 313():43-51. PubMed ID: 28110884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
    Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
    BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells.
    Kumagai S; Togashi Y; Sakai C; Kawazoe A; Kawazu M; Ueno T; Sato E; Kuwata T; Kinoshita T; Yamamoto M; Nomura S; Tsukamoto T; Mano H; Shitara K; Nishikawa H
    Immunity; 2020 Jul; 53(1):187-203.e8. PubMed ID: 32640259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIGIT and PD-1 may serve as potential prognostic biomarkers for gastric cancer.
    Xu D; Zhao E; Zhu C; Zhao W; Wang C; Zhang Z; Zhao G
    Immunobiology; 2020 May; 225(3):151915. PubMed ID: 32122675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment.
    Shaopeng Z; Yang Z; Yuan F; Chen H; Zhengjun Q
    Cancer Med; 2024 Jan; 13(2):e6959. PubMed ID: 38349050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
    Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
    Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma.
    Chen J; Liu K; Luo Y; Kang M; Wang J; Chen G; Qi J; Wu W; Wang B; Han Y; Shi L; Wang K; Han X; Ma X; Liu W; Ding Y; Wang L; Liang H; Wang L; Chen J
    Gastroenterology; 2023 Jul; 165(1):88-103. PubMed ID: 36921674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine Generated by Regulatory T Cells Induces CD8
    Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
    Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune infiltration profiling in gastric cancer and their clinical implications.
    Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
    Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
    Wu M; Wang Y; Liu H; Song J; Ding J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.